Galapagos NV
GLPG
#4563
Rank
ยฃ1.58 B
Marketcap
ยฃ23.71
Share price
-0.57%
Change (1 day)
12.27%
Change (1 year)

Galapagos NV (GLPG) - Total debt

Total debt on the balance sheet as of September 2025 : ยฃ6.6 Million

According to Galapagos NV's latest financial reports the company's total debt is ยฃ6.6 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Galapagos NV - Total debt on balance sheet (from 2008 to 2025)

Total debt by year

Year Total debt Change
2024-12-31ยฃ9.72 M16.74%
2023-12-31ยฃ8.32 M-57.12%
2022-12-31ยฃ19.41 M-13.83%
2021-12-31ยฃ22.53 M-15.16%
2020-12-31ยฃ26.56 M22.49%
2019-12-31ยฃ21.68 M
2018-12-31N/A-100%
2017-12-31ยฃ0 M-85.12%
2016-12-31ยฃ0.05 M-36.71%
2015-12-31ยฃ0.08 M-34.96%
2014-12-31ยฃ0.13 M-60.35%
2013-12-31ยฃ0.32 M-0.73%
2012-12-31ยฃ0.33 M-54.71%
2011-12-31ยฃ0.73 M-31.77%
2010-12-31ยฃ1.07 M-18.35%
2009-12-31ยฃ1.31 M-18.3%
2008-12-31ยฃ1.6 M-49.91%
2007-12-31ยฃ3.21 M-38.64%
2006-12-31ยฃ5.23 M-4.4%
2005-12-31ยฃ5.47 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
AstraZeneca
AZN
ยฃ24.49 B 370,540.02%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
ยฃ34.37 B 520,047.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ19.16 B 289,889.02%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
ยฃ51.60 B 780,695.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
ยฃ51.95 M 686.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
ยฃ9.71 B 146,886.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ12.81 B 193,818.15%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
ยฃ17.91 B 270,928.81%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
ยฃ31.05 B 469,833.20%๐Ÿ‡บ๐Ÿ‡ธ USA